Clinical trial
German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa
NCT06095713 is registered in ClinicalTrials.gov with Universität Münster as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa
- Lead sponsor
- Universität Münster
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 1, 2023
- Completion date
- September 30, 2027
- Enrollment
- 60 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.